GlaxoSmithKlineThe Impact of Medicines: Sustainability in Environment, Health and Safety Report 2002
Reporting Front PageDownloads
EHS 2002 home

About this report

Executive statements

Chairman of the Board

Chief Executive Officer

SVP and General Counsel

VP Corporate Environment, Health and Safety

VP Employee Health Management

Framework

Issues

Performance

Verification statement

Index
Executive statements
Executive Statements
Previous
Next
 
 


Sir Christopher Hogg - Chairman of the Board   Dr. JP Garnier - Chief Executive Officer   Rupert Bondy - SVP and General Counsel
Sir Christopher Hogg - Chairman of the Board   Dr. JP Garnier - Chief Executive Officer   Rupert Bondy - Senior Vice President and General Counsel
             
Dr. James Hagan - Vice President Corporate Environment, Health and Safety     Dr. Robert W. Carr - Vice President Corporate Employee Health Management      


Previous
Next


Top


EHS 2002 Home | Reporting Front Page | Downloads | Main Site
 
Updated July 21, 2003 - © 2005 GlaxoSmithKline - All Rights Reserved
Legal Notices - Privacy Statement